Archive: Prescription for Change at the FDA: A View from the Other Washington, Part 2
84 views · Published 20 October 2010 · 53:09 · Indexed 20 September 2026
Channel: UW Video · 2010 · Education
Professors at the University of Washington ask: Does the Food and Drug Administration need more rigorous reviews and trials before approving drugs and devices? Should the agency change the process for evaluating safety and effectiveness after products hit the market? What are the political and scientific forces that shape the context for FDA decision-making and how can the clinical and public health communities be included in the discussion? This is the second half of a two-part program on this topic. The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.
More from this channel
-
53:34
Archive: Closing the Innovation Gap
-
52:34
Archive: Hardness Amplification by Repetition
-
27:18
Archive: Eastside Specialty Center: Coordination of Care
-
22:35
Archive: Innovations in Spine Care
-
28:49
Archive: UW Sports Medicine For Every Athlete
-
58:21
Archive: Sustainable Urban Ecosystems: Physical and Biological Environments, Part 1
-
57:55
Archive: Sustainable Urban Ecosystems: Physical and Biological Environments, Part 2
-
56:54
Archive: Tribal Forestry: Part 2 - Opportunities and Challenges for Tribal Forestry